ELAB vs PEAK
Elevai Labs, Inc. Common Stock (ELAB) versus PEAK (PEAK) — a side-by-side from cached financials, not a winner call.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
PEAK (PEAK) common stock.
Latest reported ELAB revenue for 2026-06-30 was $2.0M. Net income was -$7.9M. ELAB currently screens at market cap $6.5M.
PEAK does not have a complete income-statement cache yet.
ELAB currently screens at market cap $6.5M.
Not investment advice. Open the ELAB and PEAK stock pages for the full models.
Not investment advice.